U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07727954) titled 'Efficacy and Safety of a Combined Topical Formula Versus Placebo in Patients With Melasma' on July 22.
Brief Summary: The goal of this clinical trial is to learn whether a topical formulation containing 12% azelaic acid and 5% tranexamic acid is effective and safe for treating melasma in adults. The main questions it aims to answer are:
Does the topical formulation reduce melasma severity compared with placebo after 4 weeks of treatment? Is the topical formulation safe and well tolerated?
Researchers will compare the active topical formulation with a placebo cream to determine whether the active treatment provides greater improvem...